Nabriva Therapeutics AG

  • Founded in 2006
  • Employees: 52
  • Financial data: €243M Market Cap (on 13/02/2017)

Description :

Nabriva Therapeutics is a company focused on developing a new class of antibiotics, pleuromutilins, for the treatment of patients with serious infections caused by multi-drug resistant pathogens.

Headquarters :

Leberstrasse 20 1110 Vienna

We use cookies to give you the best experience and for advertising purposes. By accepting, you support our independent media and it's freely accessible content.